Clinical Trials Logo

Endometrial Stromal Tumors clinical trials

View clinical trials related to Endometrial Stromal Tumors.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00505739 Completed - Endometrial Cancer Clinical Trials

Mifepristone for Patients With Endometrial Cancer and LGESS

Start date: September 2001
Phase: Phase 2
Study type: Interventional

Primary Objectives: 1. To determine the antitumor activity of Mifepristone (RU-486) in patients with advanced or recurrent endometrioid adenocarcinoma or low grade endometrial stromal sarcoma (LGESS). 2. To evaluate the quantitative and qualitative toxicities of Mifepristone in this patient population. 3. To evaluate at a tissue level the effect of Mifepristone on estrogen and progesterone receptors post treatment and to evaluate other markers that may reflect effects of Mifepristone on cancer cell growth. 4. To evaluate the effect of the agent and dosing schedule on the patient's quality of life.